BioNTech SE Files 2024 Annual Report

Ticker: BNTX · Form: 20-F · Filed: 2025-03-10T00:00:00.000Z

Sentiment: neutral

Topics: annual-report, biotechnology, financials

TL;DR

BioNTech dropped its 2024 20-F, check it for the latest on their financials and biz.

AI Summary

BioNTech SE filed its 20-F annual report for the fiscal year ending December 31, 2024. The report details the company's financial performance and business operations, including its significant role in vaccine development. Key financial figures and operational highlights for 2024 are presented within the filing.

Why It Matters

This filing provides investors and the public with a comprehensive overview of BioNTech's financial health and strategic direction for the past fiscal year, crucial for understanding its ongoing contributions to biotechnology.

Risk Assessment

Risk Level: medium — As a biotechnology company, BioNTech faces inherent risks related to drug development, regulatory approvals, and market competition, which are detailed in its 20-F filing.

Key Numbers

2024 — Fiscal Year (The period covered by the annual report)
1231 — Fiscal Year End (Indicates the end of the reporting period)

Key Players & Entities

BioNTech SE (company) — Filer of the 20-F report
2024-12-31 (date) — Fiscal year end date
2025-03-10 (date) — Filing date
Mainz (location) — Company headquarters city

FAQ

What is the primary business of BioNTech SE?

BioNTech SE is primarily involved in the development of biological products, specifically vaccines and immunotherapies, as indicated by its SIC code 2836.

What is the filing date of this 20-F report?

This 20-F report was filed as of March 10, 2025.

What is the fiscal year end for BioNTech SE?

BioNTech SE's fiscal year ends on December 31st.

Where is BioNTech SE headquartered?

BioNTech SE is headquartered in Mainz, Germany.

What is the SEC file number for BioNTech SE?

The SEC file number for BioNTech SE is 001-39081.

From the Filing

0001776985-25-000013.txt : 20250310 0001776985-25-000013.hdr.sgml : 20250310 20250310070014 ACCESSION NUMBER: 0001776985-25-000013 CONFORMED SUBMISSION TYPE: 20-F PUBLIC DOCUMENT COUNT: 145 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250310 DATE AS OF CHANGE: 20250310 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioNTech SE CENTRAL INDEX KEY: 0001776985 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: 2M FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 20-F SEC ACT: 1934 Act SEC FILE NUMBER: 001-39081 FILM NUMBER: 25722114 BUSINESS ADDRESS: STREET 1: AN DER GOLDGRUBE 12 CITY: MAINZ STATE: 2M ZIP: 55131 BUSINESS PHONE: 0049613190840 MAIL ADDRESS: STREET 1: AN DER GOLDGRUBE 12 CITY: MAINZ STATE: 2M ZIP: 55131 20-F 1 bntx-20241231.htm 20-F bntx-20241231 FALSE FY 2024 0001776985 true P4Y xbrli:shares iso4217:EUR iso4217:EUR xbrli:shares xbrli:pure iso4217:USD utr:Y iso4217:USD xbrli:shares 0001776985 2024-01-01 2024-12-31 0001776985 dei:BusinessContactMember 2024-01-01 2024-12-31 0001776985 bntx:AmericanDepositarySharesEachRepresentingOneOrdinaryShareMember 2024-01-01 2024-12-31 0001776985 bntx:OrdinarySharesNoParValueWithNationalAmountAttributableToEachOrdinaryShareMember 2024-01-01 2024-12-31 0001776985 2025-03-03 0001776985 2023-01-01 2023-12-31 0001776985 2022-01-01 2022-12-31 0001776985 2024-12-31 0001776985 2023-12-31 0001776985 ifrs-full:IssuedCapitalMember 2021-12-31 0001776985 ifrs-full:CapitalReserveMember 2021-12-31 0001776985 ifrs-full:TreasurySharesMember 2021-12-31 0001776985 ifrs-full:RetainedEarningsMember 2021-12-31 0001776985 ifrs-full:OtherReservesMember 2021-12-31 0001776985 2021-12-31 0001776985 ifrs-full:RetainedEarningsMember 2022-01-01 2022-12-31 0001776985 ifrs-full:OtherReservesMember 2022-01-01 2022-12-31 0001776985 ifrs-full:IssuedCapitalMember 2022-01-01 2022-12-31 0001776985 ifrs-full:CapitalReserveMember 2022-01-01 2022-12-31 0001776985 ifrs-full:TreasurySharesMember 2022-01-01 2022-12-31 0001776985 ifrs-full:IssuedCapitalMember 2022-12-31 0001776985 ifrs-full:CapitalReserveMember 2022-12-31 0001776985 ifrs-full:TreasurySharesMember 2022-12-31 0001776985 ifrs-full:RetainedEarningsMember 2022-12-31 0001776985 ifrs-full:OtherReservesMember 2022-12-31 0001776985 2022-12-31 0001776985 ifrs-full:RetainedEarningsMember 2023-01-01 2023-12-31 0001776985 ifrs-full:OtherReservesMember 2023-01-01 2023-12-31 0001776985 ifrs-full:CapitalReserveMember 2023-01-01 2023-12-31 0001776985 ifrs-full:TreasurySharesMember 2023-01-01 2023-12-31 0001776985 ifrs-full:IssuedCapitalMember 2023-12-31 0001776985 ifrs-full:CapitalReserveMember 2023-12-31 0001776985 ifrs-full:TreasurySharesMember 2023-12-31 0001776985 ifrs-full:RetainedEarningsMember 2023-12-31 0001776985 ifrs-full:OtherReservesMember 2023-12-31 0001776985 ifrs-full:RetainedEarningsMember 2024-01-01 2024-12-31 0001776985 ifrs-full:OtherReservesMember 2024-01-01 2024-12-31 0001776985 ifrs-full:CapitalReserveMember 2024-01-01 2024-12-31 0001776985 ifrs-full:TreasurySharesMember 2024-01-01 2024-12-31 0001776985 ifrs-full:IssuedCapitalMember 2024-12-31 0001776985 ifrs-full:CapitalReserveMember 2024-12-31 0001776985 ifrs-full:TreasurySharesMember 2024-12-31 0001776985 ifrs-full:RetainedEarningsMember 2024-12-31 0001776985 ifrs-full:OtherReservesMember 2024-12-31 0001776985 bntx:IntellectualPropertyRightsMember ifrs-full:BottomOfRangeMember 2024-01-01 2024-12-31 0001776985 bntx:IntellectualPropertyRightsMember ifrs-full:TopOfRangeMember 2024-01-01 2024-12-31 0001776985 ifrs-full:LicencesMember ifrs-full:BottomOfRangeMember 2024-01-01 2024-12-31 0001776985 ifrs-full:LicencesMember ifrs-full:TopOfRangeMember 2024-01-01 2024-12-31 0001776985 ifrs-full:ComputerSoftwareMember ifrs-full:BottomOfRangeMember 2024-01-01 2024-12-31 0001776985 ifrs-full:ComputerSoftwareMember ifrs-full:TopOfRangeMember 2024-01-01 2024-12-31 0001776985 ifrs-full:Bui